VeriSign wins patent for Internet typo redirection: related news

Mylan wins generic Prilosec patent litigation

Add our medical news to digg - Mylan wins generic Prilosec patent litigation Add our medical news to NewsVine - Mylan wins generic Prilosec patent litigation Add our medical news to Fark - Mylan wins generic Prilosec patent litigation Add our medical news to Furl - Mylan wins generic Prilosec patent litigation Add our medical news to Shadows - Mylan wins generic Prilosec patent litigation Add our medical news to YahooMyWeb - Mylan wins generic Prilosec patent litigation Add our medical news to Reddit -Mylan wins generic Prilosec patent litigation Add our medical news to StumbleUpon - Mylan wins generic Prilosec patent litigation Add our medical news to Facebook - Mylan wins generic Prilosec patent litigation

Biopure Corporation wins European patent challenge

Add our medical news to digg - Biopure Corporation wins European patent challenge Add our medical news to NewsVine - Biopure Corporation wins European patent challenge Add our medical news to Fark - Biopure Corporation wins European patent challenge Add our medical news to Furl - Biopure Corporation wins European patent challenge Add our medical news to Shadows - Biopure Corporation wins European patent challenge Add our medical news to YahooMyWeb - Biopure Corporation wins European patent challenge Add our medical news to Reddit -Biopure Corporation wins European patent challenge Add our medical news to StumbleUpon - Biopure Corporation wins European patent challenge Add our medical news to Facebook - Biopure Corporation wins European patent challenge

VeriSign wins patent for Internet typo redirection

The company that runs many of the Internet's core directory systems has won a patent for its controversial service that helps Internet users find sites even when they mistype addresses.

VeriSign wins patent for Internet typo redirection

The company that runs many of the Internet's core directory systems has won a patent for its controversial service that helps Internet users find sites even when they mistype addresses.

VeriSign wins patent for Internet typo redirection

The company that runs many of the Internet's core directory systems has won a patent for its controversial service that helps Internet users find sites even when they mistype addresses.

VeriSign wins patent for Internet typo redirection

The company that runs many of the Internet's core directory systems has won a patent for its controversial service that helps Internet users find sites even when they mistype addresses.

VeriSign wins patent for Internet typo redirection

NEW YORK - The company that runs many of the Internet's core directory systems has won a patent for its controversial service that helps Internet users find sites even when they mistype addresses.

VeriSign wins patent for Internet typo redirection

NEW YORK-The company that runs many of the Internet's core directory systems has won a patent for its controversial service that helps Internet users find sites even when they mistype addresses.

VeriSign wins patent for Internet typo redirection

NEW YORK (AP) - The company that runs many of the Internet's core directory systems has won a patent for its controversial service that helps Internet users find sites even when they mistype addresses.

VeriSign Wins Patent for Internet Typo Redirection

Just when you thought you’d heard the last of that Site Finder crap, it is back in the news again because VeriSign was granted a patent on redirecting mistyped addresses. The company says it has no plans on resurrecting Site Finder but you have to wonder, why did they apply for a patent unless they were going to use it?

VeriSign Wins Patent for Internet Typo Redirection

Although Time Warner Inc.'s AOL, Microsoft Corp.'s Internet Explorer browser and others already offered similar services, VeriSign was criticized when it launched Site Finder in 2003 because of the influence the company already had as the keeper of the traffic-control directories containing all ".com" and ".net" names.

Barr confirms patent challenge of Prevacid SoluTab tablets

Add our medical news to digg - Barr confirms patent challenge of Prevacid SoluTab tablets Add our medical news to NewsVine - Barr confirms patent challenge of Prevacid SoluTab tablets Add our medical news to Fark - Barr confirms patent challenge of Prevacid SoluTab tablets Add our medical news to Furl - Barr confirms patent challenge of Prevacid SoluTab tablets Add our medical news to Shadows - Barr confirms patent challenge of Prevacid SoluTab tablets Add our medical news to YahooMyWeb - Barr confirms patent challenge of Prevacid SoluTab tablets Add our medical news to Reddit -Barr confirms patent challenge of Prevacid SoluTab tablets Add our medical news to StumbleUpon - Barr confirms patent challenge of Prevacid SoluTab tablets Add our medical news to Facebook - Barr confirms patent challenge of Prevacid SoluTab tablets

Barr confirms Entocort patent challenge

Add our medical news to digg - Barr confirms Entocort patent challenge Add our medical news to NewsVine - Barr confirms Entocort patent challenge Add our medical news to Fark - Barr confirms Entocort patent challenge Add our medical news to Furl - Barr confirms Entocort patent challenge Add our medical news to Shadows - Barr confirms Entocort patent challenge Add our medical news to YahooMyWeb - Barr confirms Entocort patent challenge Add our medical news to Reddit -Barr confirms Entocort patent challenge Add our medical news to StumbleUpon - Barr confirms Entocort patent challenge Add our medical news to Facebook - Barr confirms Entocort patent challenge

EntreMed receives new patent for 2-Methoxyestradiol analogs

Add our medical news to digg - EntreMed receives new patent for 2-Methoxyestradiol analogs Add our medical news to NewsVine - EntreMed receives new patent for 2-Methoxyestradiol analogs Add our medical news to Fark - EntreMed receives new patent for 2-Methoxyestradiol analogs Add our medical news to Furl - EntreMed receives new patent for 2-Methoxyestradiol analogs Add our medical news to Shadows - EntreMed receives new patent for 2-Methoxyestradiol analogs Add our medical news to YahooMyWeb - EntreMed receives new patent for 2-Methoxyestradiol analogs Add our medical news to Reddit -EntreMed receives new patent for 2-Methoxyestradiol analogs Add our medical news to StumbleUpon - EntreMed receives new patent for 2-Methoxyestradiol analogs Add our medical news to Facebook - EntreMed receives new patent for 2-Methoxyestradiol analogs

VeriSign wins patent for typo redirection

VeriSign said it has no intentions of resurrecting the Site Finder service, but it declined further comment on its plans for the patent, including bloggers' speculation that it could now demand licensing fees from EarthLink and other companies that have since started similar efforts.

Nintendo Loses Patent Suit In East Texas, Of Course

The latest in a long line of patent lawsuits in every patent hoarders favorite district of East Texas involves the game controllers used by Nintendo. A company holds a patent on a 3D controller and sued Nintendo (and Microsoft) for supposedly violating the patent. Not surprisingly, the jury found in favor of the patent holder. Juries quite often side with the patent holder, no matter how questionable the patent may be. In this case, there would seem to be a ton of prior art raising validity questions. The patent itself was filed in November of 2000, at which point there were already numerous game controllers that seem to meet most of the criteria outlined in the claims. Whatever minor differences there may have been between what was on the market and what's in the claims should be seen as an obvious iteration of game controllers.

febit receives U.S. patent for microfluidic extraction method

Add our medical news to digg - febit receives U.S. patent for microfluidic extraction method Add our medical news to NewsVine - febit receives U.S. patent for microfluidic extraction method Add our medical news to Fark - febit receives U.S. patent for microfluidic extraction method Add our medical news to Furl - febit receives U.S. patent for microfluidic extraction method Add our medical news to Shadows - febit receives U.S. patent for microfluidic extraction method Add our medical news to YahooMyWeb - febit receives U.S. patent for microfluidic extraction method Add our medical news to Reddit -febit receives U.S. patent for microfluidic extraction method Add our medical news to StumbleUpon - febit receives U.S. patent for microfluidic extraction method Add our medical news to Facebook - febit receives U.

Drugs industry protecting 'morally unacceptable' patent system

Add our medical news to digg - Drugs industry protecting 'morally unacceptable' patent system Add our medical news to NewsVine - Drugs industry protecting 'morally unacceptable' patent system Add our medical news to Fark - Drugs industry protecting 'morally unacceptable' patent system Add our medical news to Furl - Drugs industry protecting 'morally unacceptable' patent system Add our medical news to Shadows - Drugs industry protecting 'morally unacceptable' patent system Add our medical news to YahooMyWeb - Drugs industry protecting 'morally unacceptable' patent system Add our medical news to Reddit -Drugs industry protecting 'morally unacceptable' patent system Add our medical news to StumbleUpon - Drugs industry protecting 'morally unacceptable' patent system Add our medical news to Facebook - Drugs industry protecting 'morally unaccep

VeriSign wins patent for Internet typo redirection but won't disclose plans for the tech

Exporting Financing Human Resources Managing Personal Development Sales & Marketing Startup Guide Technology

Environmental Control Corporation Acquires Second Canadian Patent

VANCOUVER, BC -- 05/20/08 -- Environmental Control Corporation ("EVCC") (OTCBB: EVCC) -- It is with great pleasure that Environmental Control Corporation ("EVCC") (OTCBB: EVCC) announces the approval of its second Canadian Patent. The Reverse Flow Catalytic Muffler, Canadian Patent # 2,448,648, now accompanies Canadian Patent # 2,448,742 -- The Combined Catalytic Muffler. Other intellectual property currently held by EVCC includes two U.S. Patents: The Reverse Flow Catalytic Muffler (U.S. Patent # 7,018,590) and The Combined Catalytic Muffler (U.S. Patent # 6,622,482); and one pending patent in Europe: the Reverse Flow Catalytic Muffler (Patent Application # 02742591.7). It is anticipated that the European patent application will be approved and registered in the near future.

VeriSign Gets Typo-Redirection Patent

The company that runs many of the Internet's core directory systems has won a patent for its controversial service that helps Internet users find sites even when they mistype addresses.

June is ''Internet Safety Month''... Bsafe Online Internet Filter Offering Discount...

June is ''Internet Safety Month''... Bsafe Online Internet Filter Offering Discount for the Month BRISTOL, Tenn.--(Business Wire)-- Good parents have an instinctive responsibility to protect their children. However, in today's ever-changing world of technology, some parents seem to be a step behind their tech-savvy kids. The U.S. Senate unanimously passed a resolution declaring June to be Internet Safety Month. There is no better time for parents to take the necessary steps to protect their children while they surf the World Wide Web. Bsafe Online would like to make Internet Safety easier... and more affordable. Bsafe Online, Inc. is offering deep discounts on its award-winning All-in-one Security Suite and Internet filter during the month of June in honor of Internet Safety Month.

U.S. Patent on Cytori's Celution System Technology Issued; Celution System Commercialization not Impacted by Recent 6,777,231 Patent Inventorship Decision

SAN DIEGO--(BUSINESS WIRE)--Jun 24, 2008 - U.S. Patent No. 7,390,484 ("the '484 patent") covering Cytori's (NASDAQ:CYTX) Celution(R) System technology was issued today by the United States Patent and Trademark Office. The '484 patent provides Cytori critical market protection for its commercialization of the Celution System in the United States, where the Company is seeking regulatory approval. The '484 patent also protects Cytori's rights to manufacture the Celution Systems in the United States for commercialization into all markets, including Europe and Asia-Pacific, where the device is currently being sold. Other related patent filings are in progress around the globe.

Freedom Wireless, Inc. Settles Patent Infringement Suit Against VeriSign, Inc.

PHOENIX, May 21 /PRNewswire/ -- Freedom Wireless, Inc. announced today that it has settled a patent infringement suit against VeriSign, Inc. (Nasdaq: VRSN - News) pending in federal court in Marshall, Texas. Freedom Wireless and VeriSign will file a Final Consent Judgment in which they agree that Judgment may be entered for Freedom Wireless and against VeriSign on Freedom Wireless' claims that VeriSign infringed three of Freedom Wireless' patents relating to prepaid wireless systems and on VeriSign's counterclaims alleging non-infringement, invalidity and unenforceability of those patents.

VeriSign founder returns to company

VeriSign, the biggest operator of computers that direct Internet traffic, brought back founder Jim Bidzos as interim chief executive, chairman and president as the company works to refocus. Bidzos replaces former CEO William Roper, who unexpectedly resigned this week. Bidzos will help drive VeriSign's efforts to offload the less profitable businesses, the Mountain View company said Thursday in a statement. VeriSign announced plans in November to get out of businesses that don't fit with its Internet operations, such as services that cater to phone companies. Those businesses accounted for about 40 percent of revenue. VeriSign plans to focus on managing Web addresses, certifying that sites are what they claim and protecting online privacy. Bidzos, who founded the company in 1995, will lead that effort while VeriSign looks for a permanent p

Search took 0.84 seconds.